Articles From: PG&E Signs On to New White House Initiative, Announces Actions to Help Small Business Partners Grow and Prosper to Phase III FIRST™ (MM-020/IFM 07-01) Trial of REVLIMID® (lenalidomide) Plus Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Who Are Not Candidates for Stem Cell Transplant Published in New England Journal of Medicine


2014/7/11
SAN FRANCISCO , July 11, 2014 /PRNewswire/ -- Pacific Gas and Electric Company (PG&E) has pledged to help small business suppliers grow by taking active steps to speed up payments for goods and services and promote better access to financing.
Sign-up for PG&E Signs On to New White House Initiative, Announces Actions to Help Small Business Partners Grow and Prosper investment picks
SAN FRANCISCO , June 18, 2014 /PRNewswire/ -- Pacific Gas and Electric Company is urging the California Public Utilities Commission (CPUC) to provide the resources necessary to maintain safe and reliable gas and electric service while still keeping customer bills below the national average.
Sign-up for PG&E Urges CPUC to Provide the Resources Necessary for a 21st Century Energy Infrastructure that is Safer and More Reliable while Keeping Bills Below the National Average investment picks
2014/7/1
Safe Outdoor Equipment and Vehicle Use Key to Preventing Fires SAN FRANCISCO , July 1, 2014 /PRNewswire/ -- Pacific Gas and Electric Company (PG&E) and CAL FIRE today announced a partnership to help stop wildfires before they start in California .
Sign-up for PG&E, CAL FIRE Partner to Reduce Wildfire Risk investment picks
2014/8/11
New standard focuses on public safety by preventing damage to underground utility lines SAN FRANCISCO , Aug.
Sign-up for PG&E's Gold Shovel Standard Paves The Way For Safe Excavation investment picks
2014/8/14
PGA Tour Golfer and Team RBC Ambassador Graeme McDowell Wins Online Charity Challenge for Children's Hospital in Ireland Canada NewsWire Over $300,000 awarded to children's charities around the world through #RBCGolf4Kids TORONTO , Aug.
Sign-up for PGA Tour Golfer and Team RBC Ambassador Graeme McDowell Wins Online Charity Challenge for Children's Hospital in Ireland investment picks
2014/7/15
PONTE VEDRA BEACH, Fla.
Sign-up for PGA TOUR, Tempur-Pedic Announce New Marketing Relationship investment picks
Strategic Alliance Integrates PGi's Award-Winning iMeet® Web Conferencing with TPN's Cloud UC Platform ATLANTA , Aug.
Sign-up for PGi and Thinking Phone Networks Join Forces to Bring Cloud Collaboration to Enterprises investment picks
Company Reiterates 2014 Financial Outlook, Including Accelerated SaaS Growth Investments; Projects 2014 Free Cash Flow to Exceed $1.00 Per Share* ATLANTA , July 17, 2014 /PRNewswire/ -- Premiere Global Services, Inc. (NYSE: PGI) , a leading global provider of collaboration software and services for over 20 years, today announced results for the second quarter ended June 30, 2014 .
Sign-up for PGi SaaS Products Revenue Up Over 50% in Second Quarter 2014; Total Revenues Up Over 9% to $144.3M, Non-GAAP Diluted EPS from Continuing Ops $0.23* investment picks
ATLANTA , July 7, 2014 /PRNewswire/ -- Premiere Global Services, Inc. (NYSE: PGI) , a leading global provider of collaboration software and services for over 20 years, today announced that it plans to release results for the second quarter ended June 30, 2014 , after the market close on July 17, 2014 .
Sign-up for PGi to Announce Second Quarter 2014 Results on Thursday, July 17, 2014 investment picks
VENICE, Fla., July 28, 2014 (GLOBE NEWSWIRE) -- PGT, Inc. (Nasdaq:PGTI) , the leading U.S. manufacturer and supplier of residential impact-resistant windows and doors, announces updated conference call date and time to discuss our financial results for our second quarter and six months ended June 28, 2014.
Sign-up for PGT Earnings Release Conference Call Date and Time Change investment picks
N. VENICE, Fla., June 24, 2014 (GLOBE NEWSWIRE) -- PGT Industries (Nasdaq:PGTI) , the nation's leading manufacturer and supplier of residential impact-resistant windows and doors, has awarded the PGT Talent for Tomorrow Scholarship to Katlyn Nau as part of its participation in the American Architectural Manufacturers Association (AAMA) Scholarship Partner Program.
Sign-up for PGT Industries Awards 2014 Scholarship investment picks
VENICE, Fla., July 28, 2014 (GLOBE NEWSWIRE) -- PGT, Inc. (Nasdaq:PGTI) , the leading U.S. manufacturer and supplier of residential impact-resistant windows and doors, announces financial results for its second quarter and six months ended June 28, 2014.
Sign-up for PGT Reports 2014 Second Quarter Results investment picks
N. VENICE, Fla., July 28, 2014 (GLOBE NEWSWIRE) -- PGT, Inc. (Nasdaq:PGTI) , the nation's leading manufacturer and supplier of residential impact-resistant windows and doors, announced today that it has entered into a definitive agreement with CGI Windows & Doors Holdings, Inc. (a portfolio company of Cortec Group Fund, IV, LP) pursuant to which CGI will become a wholly owned subsidiary of PGT.
Sign-up for PGT to Acquire CGI Windows & Doors Holdings, Inc. investment picks
VENICE, Fla., June 30, 2014 (GLOBE NEWSWIRE) -- PGT, Inc. (Nasdaq:PGTI) will host a conference call on Thursday, July 31, 2014, to discuss the company's second quarter results, as well as other business matters.
Sign-up for PGT, Inc. Announces 2014 Second Quarter Results Conference Call investment picks
SUNNYVALE, Calif.
Sign-up for Pharmacyclics Appoints Chief Commercial Officer investment picks
- IMBRUVICA Net Product Revenue Increased to $109.5 million for the Second Quarter of 2014 - SUNNYVALE, Calif.
Sign-up for Pharmacyclics Reports Second Quarter 2014 Results investment picks
2014/9/8
Companies Combine Expertise and Resources to Advance Medical Countermeasures Development and Manufacturing ANNAPOLIS, Md.
Sign-up for PharmAthene and Nanotherapeutics Form Strategic Alliance to Advance Biodefense Programs investment picks
2014/8/4
ANNAPOLIS, Md.
Sign-up for PharmAthene Reports Second Quarter 2014 Financial And Operational Results investment picks
PharMerica Corporation (NYSE:PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, announced today that it has completed the acquisition of Rx Advantage, Inc. Rx Advantage provides comprehensive pharmacy services to long-term care facilities and other customers, primarily in Alabama and Florida.
Sign-up for PharMerica Acquires Rx Advantage investment picks
PharMerica Corporation (NYSE:PMC) announced today that it will provide an online webcast of its second quarter 2014 earnings conference call on Tuesday, August 5, 2014.
Sign-up for PharMerica Corporation Announces Second Quarter 2014 Earnings Call and Webcast investment picks
PharMerica Corporation (NYSE:PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today raised its full year 2014 guidance metrics.
Sign-up for Pharmerica Raises 2014 Earnings Guidance investment picks
PharMerica Corporation (NYSE:PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today reported its financial results for the second quarter and six months ended June 30, 2014.
Sign-up for PharMerica Reports Second Quarter 2014 Results investment picks
Bristol-Myers Squibb Company (NYSE:BMY) today announced that a randomized blinded comparative Phase 3 study evaluating nivolumab versus dacarbazine (DTIC) in patients with previously untreated BRAF wild-type advanced melanoma was stopped early because an analysis conducted by the independent Data Monitoring Committee (DMC) showed evidence of superior overall survival in patients receiving nivolumab compared to the control arm.
Sign-up for Phase 3 First-Line Melanoma Study of Nivolumab, an Investigational PD-1 Checkpoint Inhibitor, Demonstrates Superior Overall Survival Compared to Dacarbazine; Study Stopped Early investment picks
Celgene Corporation (NASDAQ:CELG) today announced that data from FIRST (MM-020/IFM 07-01)—an open-label phase III randomized study of continuous REVLIMID (lenalidomide) in combination with dexamethasone in patients newly diagnosed with multiple myeloma (NDMM) who are not candidates for stem cell transplant—have been published in the Sept.
Sign-up for Phase III FIRST™ (MM-020/IFM 07-01) Trial of REVLIMID® (lenalidomide) Plus Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Who Are Not Candidates for Stem Cell Transplant Published in New England Journal of Medicine investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: PG&E Signs On to New White House Initiative, Announces Actions to Help Small Business Partners Grow and Prosper to Phase III FIRST™ (MM-020/IFM 07-01) Trial of REVLIMID® (lenalidomide) Plus Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Who Are Not Candidates for Stem Cell Transplant Published in New England Journal of Medicine
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices